武汉百纳礼康生物制药有限公司

Nano liquid-crystal gel sustained-release platform that reformulates drugs for Alzheimer's, oncology, anesthesia and endocrine therapies into biodegradable depot microspheres, microcapsules or liposomal injectable long-acting formulations. Platform reduces organic solvent residue, enables flexible lipid-ratio formulations with good injectability, and matches conventional sustained‑release performance.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading